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ABSTRACT

Infection with herpes simplex virus type 1 leads to a lifelong presence o f the vims
in the host typified by the punctuated recrudescence o f herpetic lesions of the orofacial
region. Recmdescence of symptoms is due to the ability o f the virus to reactivate from a
latent state in neurons of the trigeminal ganglia. The latent state characterized by a
complete lack of DNA replication, absence o f virion stmctural protein production, and
the minimal expression of a very limited set o f regulatory genes. Reactivation is seen as
the return to full viral gene expression, production o f new infectious virions, and the
emergence of clinical symptoms o f herpetic disease. The viral transactivator ICPO has
been implicated in both latency and reactivation. PC 12 cells neurally differentiated by
nerve growth factor were used as host cells to attempt to generate a quiescent infection. A
viral construct deletion mutant GHSV-UL46 that lacks the ICP4 transactivator genes, has
a defective US3, and has green fluorescent protein gene attached to gene UL46 was used.
Roscovitine, a small molecule inhibitor o f cyclin dependent kinases, was used for its
ability to prevent ICPO activity via prevention o f ICPO’s phosphorylation by cyclindependent kinase 5. Inhibition of ICPO transactivity with roscovitine did not shift
expression equilibrium towards latency. The use of an inhibitor o f MEK1, PD98059,
however, showed better inhibition o f GFP expression than either roscovitine or acyclovir.
The data indicates that a low-level productive infection was achieved as opposed to a
quiescent infection, while studies of small molecule inhibitors posit the possibility that
the molecular events of a low-level productive infection differ from those o f a fully
productive infection.
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INTRODUCTION

Herpes simplex virus type 1 (HSV-1) belongs to a family o f DNA viruses that are
capable of establishing a lifelong infection in their hosts by entering into a latent state
that is characterized by a lack of replication o f viral DNA genome and extremely limited
transcription of a small set of genes. HSV-Ts biphasic lifestyle begins with a lytic
infection of epithelial cells (typically oral) that produces new virions that proceed into
nearby neurons (Cook, Bastone and Stevens 1974; Stevens et al. 1987) via retrograde
axonal transport, where a latent state ultimately results (Stevens 1975). A return to
productive activity from latency is termed reactivation, and occurs periodically in
neurons that receive a variety of stressful stimuli, among them physical (Valyi-Nagi et al.
1991), radioactive (Laycock et al. 1991), and hyperthermic (Halford, Gephart and Carr
1996) stresses.

The genome of HSV-1 can be organized into three gene categories with each
category activated after another in a temporal cascade during infection (Honess and
Roizman 1974). The first five genes to be expressed when the virus enters a permissive
cell are termed the immediate-early (IE) genes (Honess and Roizman 1974; Pereira et al.
1977; Purifoy and Powell 1976). IE genes express products that function as
transactivators and repressors that up- and downregulate the early (E) and late (L) genes,
as well as the IE genes themselves. Viral protein 16 (VP16), a protein that is packaged
within the virion (Batterson and Roizman 1983; Post, Mackem and Roizman 1981)
activates the expression of the IE genes upon infection (Campbell, Palfreyman and
Preston 1984). The E genes code for replicative and immune modulating enzymes. The L
genes code for viral structural proteins. The E and L genes are only expressed during a
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productive infection and are largely silenced in latency (Ward and Roizman 1994). The
latent phase itself is characterized in part by the abundant presence of alternatively
spliced mRNAs termed latency-associated-transcripts (LATs; Deatly et al. 1987; Stevens
et al. 1987). Initially it was thought that viral gene expression during latency was limited
to the LATs, but more sensitive assays have shown that low levels o f the IE gene
products infected cell polypeptide (ICP) 0 and ICP4, as well as the E gene products ICP6
(viral ribonucleotide reductase) and the viral thymidine kinase are also present during
latent infection (Chen et al. 2002; Kramer and Coen 1995; Tal-Singer et al. 1997).

ICPO and ICP4 are products o f IE genes that regulate the activity o f the rest o f the
HSV-1 genome. ICPO is a promiscuous transactivator if the viral genome that also has
been shown to interact with cellular proteins (Jordan and Schaffer 1997). It has been
shown that overexpression of ICPO in latently infected cells is sufficient for reactivation
(Mavromara-Nazos et al. 1986). However, controversy exists as to how central the role of
ICPO is in latency and reactivation: work done on mouse and rabbit latency models have
shown ICPO to be necessary for efficient reactivation (Honess and Roizman 1984), but
work done on cultured cells has resulted in contrary data suggesting its non-necessity
(Miller 2006). ICP4 is also a transactivator o f E and L genes (Gelman and Silverstein
1986), but interestingly also has the ability to function as a repressor o f itself and as well
as ICPO (Lee and Schaffer 1998; Michael and Roizman 1993). When ICPO and ICP4 are
both present, an apparent synergism occurs that appears to bolster their transactivating
activity some 20 times more than the activity of either alone (Everett 1984; Gelman and
Silverstein 1986).
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Recently, experimental support has been given to a hypothesis that suggests ICPO
complexes with ICP4, and the resulting ICP0-ICP4 complex represses the expression of
ICP4 gene in a manner reminiscent of the bacteriophage A, repressor/antirepressor switch
that regulates lysogenic and lytic cycles (Liu et al. 2010). The report showed that ICP4
functions as the repressor that prevents the expression of ICPO, thereby shifting the
kinetic equilibrium towards latency. If ICPO accumulates either by a high multiplicity of
infection (MOI) or by being transactivated in some other way that bypasses ICP4’s
silencing activity, then the complexing o f ICPO with ICP4 eliminates ICP4’s repressive
activity, allowing more ICPO to be produced and shifting the virus towards a productive
infection. Thus, ICPO functions as the antirepressor.

To further investigate this relationship, the PC 12 cell system was employed,
which has been shown to be able to support a latent-like HSV-1 infection, termed
“quiescence” in cell culture to distinguish it from in vivo models (Danaher et al. 1999;
Danaher, Jacob and Miller 1999; Danaher et al. 2008; Miller, Danaher and Jacob 2006;
Miller et al,. 2003; Su et al. 1999; Su et al. 2000; Su et al. 2002). PC 12 cells were
originally harvested from a rat pheochromocytoma (cancer o f adrenal tissue) tumor and
cultured (Greene and Tischler 1976). As with the cancerous phenotype o f other cells,
these cells exist in a partially undifferentiated state. Originating in development from the
neural crest, these cells can either be induced to differentiate into chromaffin cells or
neurons. PC 12 cells will assume partial neuronal phenotypes with the addition o f nerve
growth factor (NGF) to culture medium. Neurally-differentiated (ND) phenotypes include
the formation of long neuritic processes that can carry action potentials, the cessation of
mitotic activity, the synthesis, storage, uptake and release o f catecholamines, and other
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biochemical properties in common with peripheral neurons (Greene 1978; Greene and
Tischler 1976). Using the PC 12 cell system provides for a renewable and homogeneous
cell population that is difficult to obtain in tissue culture or in vivo explant models.

Quiescently infected (QIF) ND-PC12 (QIF-PC12) cells are defined by their
ability to persist in culture for weeks without the detectable presence of virus after an
initial brief productive period immediately following infection. Reactivation and recovery
of infectious virus can be performed at any time during the quiescent period using heat or
chemical agents (Danaher, Jacob and Miller 1999; Danaher et al. 1999). The QIF-PC12
model has been shown to produce results that are comparable to those seen in vivo: the
circularization of the HSV-1 genome upon infection occurs in QIF-PC12 cultures (Su et
al. 2002) as it does in vivo (Efstathiou et al. 1986, Rock and Fraser 1983), a 10 day
treatment of acyclovir (ACV) establishes quiescence in infected ND-PC12 cultures
(Danaher, Jacob, and Miller 1999) as it does in vivo (Wilcox and Johnson 1988),
forskolin treatment causes reactivation in QIF-PC12 cultures (Danaher, Jacob, and Miller
1999) as it does in vivo (Smith et al. 1992), reactivation occurs in a minority o f cells in
QIF-PC12 cultures (Danaher et al. 1999) as it does in vivo (Sawtell and Thompson 1992),
comparable numbers of viral genomes exist within cells of QIF-PC12 cultures as cells of
tissue explants (Miller et al. 2003), and similarity o f reactivation efficiencies after
establishment of a quiescent infection using respective wild type and mutant viruses
(Miller et al. 2003).

The virus used was GHSV-UL46, a recombinant mutant with a number of
modifications that made it suitable for this study (Willard 2002). GHSV-UL46 is derived
from mutant dl 20, which itself is a deletion mutant derived from wild-type strain KOS
4

that has the ICP4 genes deleted and a defective US3 gene (DeLuca, McCarthy and
Shaffer 1985). dl20 has been shown to be a potent inducer o f apoptosis in the dividing
cell lines: Vero, SK-N-SH, Hep-2, and HEL (Galvan, Brandimarti and Roizman 1998;
Galvan and Roizman 1999; Leopardi and Roizman 1996; Leopardi, Van Sant and
Roizman 1997; Munger, Chee and Roizman 2001; Zhou and Roizman 2000) due to its
defective US3, a gene that functions in the prevention of apoptosis (Benetti, Munger and
Roizman 2003; Benetti and Roizman 2004; Jerome et al. 1999). It has previously been
shown that dl20 does not induce widespread apoptosis in ND-PC12 cells as it does in
dividing cell lines (Aiamkitsumrit et al. 2007).

GHSV-UL46 differs from d 120 in that it has the green fluorescent protein (GFP)
gene inserted into gene UL46 that codes for a major tegument protein, allowing for direct
visualization of the virus within cells using fluorescence microscopy (Willard 2002).
Since GFP is expressed as part of the structural tegument proteins which fall under the L
temporal category, virus will be seen only in cells that are actively producing new virions
as part o f a productive infection. This attribute makes GHSV-UL46 an ideal candidate for
latency studies.
Curiously, it has been shown that another ICP4 deletion mutant, KD6, completely
failed to reactivate in QIF-PC12 cells after chemical and heat stress (Miller, Danaher and
Jacob 2006). Due to the repressor/antirepressor relationship o f ICP4 and ICP0 suggested
earlier (Liu et al. 2010), one would assume that abundant levels o f ICP0 that go
unrepressed by ICP4 would either prevent the establishment o f quiescence altogether or
render a quiescently-infected cell much more sensitive to reactivation.
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The small molecule inhibitor roscovitine (Rosco) inhibits the transactivating
activity of ICPO (Davido, Leib and Schagger 2002), possibly by interfering with ICPO’s
post-translational modifications (Advani et al. 2001; Schang, Rosenberg, and Schaffer
1999). Rosco selectively and potently inhibits cyclin-dependent kinases cdkl, cdk2, cdk5
(Meijer et al. 1997). Since mutant viruses lacking ICPO have been shown to be
complemented by cellular activity occurring in the late Gi/S phase o f the cell cycle such
as that of the cdk’s (Cai and Schaffer 1991), it would be reasonable to hypothesize that
the inhibitory effect of Rosco on ICPO is through direct inhibition o f one or more o f the
cdk’s that ICPO is dependent on and that are affected by Rosco, as opposed to direct
inhibition of the ICPO protein itself. This makes Rosco a potential candidate for use in
seeking out more specific mechanisms by which an absence of ICPO (due to
transcriptional repression by ICP4) facilitates the establishment o f latency and, later,
reactivation. In this way, Rosco is being explored as a semi-complement for ICP4’s
repressor activity that is absent in the mutant virus. Since repression o f ICPO by ICP4
results in a global nullification of ICPO-induced events, then Rosco could potentially,
after additional testing, be used as a targeted approach that removes some or all o f ICPO’s
activity while still allowing ICPO to remain in the cell. Since the mechanism o f inhibition
of Rosco is known, the role of ICPO, ICP4, and host factors in the establishment of
latency and induction of reactivation can be further explored. The purpose o f this study is
to examine the productive versus quiescent activity o f GHSV-UL46 in the context o f the
ND-PC12 model. Additionally, this study seeks to reveal if Rosco-treated ND-PC12 cells
infected with GHSV-UL46 will respond to reactivation stimuli in a wild-type manner as
established by literature despite their lack o f ICP4.
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REVIEW o f LITERATURE

Herpes simplex vims type 1 (HSV-1) belongs to a family o f DNA viruses that are
capable of establishing a lifelong infection in their hosts by entering into a latent state
that is characterized by a lack of replication o f its DNA genome and extremely limited
transcription of a small set of genes. HSV-Ts biphasic lifestyle begins with a lytic
infection of epithelial cells (typically oral) that proceeds into nearby neurons (Cook,
Bastone and Stevens 1974) via retrograde axonal transport, where a latent state ultimately
results (Stevens 1975). A return to productive activity from latency is termed
reactivation, and occurs periodically in neurons that receive a variety o f stressful stimuli,
among them physical (Valyi-Nagi et al. 1991), radioactive (Laycock et al. 1991), and
hyperthermic (Halford, Gephart and Carr 1996) stress.
Difficulties in understanding HSV-1 latency and reactivation partially stem from
the lack of a convenient neuronal cell-line for which to study the events that occur on a
molecular level. When animal models are used, problems include: heterogeneity of viral
strains making it difficult to characterize infections, heterogeneity o f harvested tissue that
may have other permissive or non-permissive cell types that may distort the perception of
latency, and host immune interactions interfering with observation of strictly virus-cell
interactions. Tissue culture systems provide some solutions but come with their own
problems, specifically the need to remove tissue from an animal system which, again,
may come with a variety of uncontrolled variables, including the stress that the animal
experiences. Cell culture then becomes an efficient alternative that may make up for what
it lacks in similarity with the in vivo systems with its relative ease o f use and superior
control of exogenous variables, although it is not a perfect system as it is conducted under
7

artificial environments that lack many of the characteristics o f true physiological
conditions. Consequently, the homogeneity of cell populations offered by cell culture
may also be disadvantageous because interactions with other cell types may strongly
influence the intracellular activity of viruses.

One such culture system is the PC 12 cell system. PC 12 cells were originally
harvested from a rat pheochromocytoma (cancer o f adrenal tissue) tumor and cultured
(Greene and Tischler 1976). Originating in development from the neural crest, these cells
can either be induced to differentiate into chromaffin cells or assume neuronal-like
phenotypes. PC 12 cells will assume partial neuronal phenotypes with the addition of
nerve growth factor (NGF) to culture medium. Phenotypes include the formation o f long
neuritic processes that can carry action potentials, the cessation o f mitotic activity, the
synthesis, storage, uptake and release o f catecholamines, and other biochemical
properties in common with peripheral neurons. (Greene 1978; Greene and Tischler 1976).
Caution must be taken in interpreting data gathered by using this cell system with HSV-1,
however, as the primary sites of HSV-1 latency are sensory neurons and ND-PC12 cells
resemble sympathetic neurons.
Attempts at setting up a long-term latent-like infection in ND-PC12 cells began
in earnest with the work of Block et al. (1994), although with some minor setbacks. This
is the work that would serve as a foundation o f more efficient ND-PC12 models for
latency in the future. Cells were plated in the presence of NGF as well as horse serum and
fetal bovine serum. Replacing medium every 3 days, after 2 weeks more than 90% of
cells had visible neurite extensions. The researchers make special note o f the observation
that adding NGF seems to cause a 50% loss o f the cell population and propose that this
8

may be due to clumping and detachment. After this 2 week period o f differentiation,
infection was carried out with HSV-1 strain 17. Within 1 week, 30% of the remaining
cells were lost, but the neuronal morphology o f remaining cells seemed to be unaffected.
The researchers reported that there was an initial 10 day surge in virus titer which then
dropped off beneath the level of detection after about 2 weeks. At 24 days post-infection
while virus titers were still less than 1,000 PFU per 75 mm2 flask, the NGF was removed
from the medium. Within 1 day, virus titers in medium increased 100-fold, confirming a
previous observation that NGF is inhibitory to reactivation (Leib et al. 1991).

Running in parallel to the NGF-deprivation experiment were infected ND-PC12
cultures maintained for four weeks without clear morphological differences to uninfected
cells and low or undetectable levels of virus in media. To see if these cells still harbored
virus in a latent state, the cells were seeded onto CV-1 cell monolayers in order to
perform an infectious center assay. Rabbit antibodies to HSV-1 were used when NDPC12 cells were harvested to ensure any virus present came from an infected ND-PC12.
Upon seeding onto the CV-1 monolayers, ND-PC12 cells began releasing virus and the
number of CV-1 plaques corresponded to the number o f ND-PC12 cells seeded, showing
that most ND-PC12 cells harbored latent virus (Block et al. 1994).
Block et al. (1994) went on further to see if the structure o f the HSV-1 genome
was non-linear in ND-PC12 cells as it was found to be in latently infected neurons of
mice. Restriction enzyme analysis strongly suggested that viral DNA isolated from long
term infected ND-PC12 cells was non-linear, while virion DNA and productivelyinfected cell (CV-1) DNA was linear. Implied is that HSV-1 DNA exists either as a
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circular concatamer or integrated into the host chromosome(s). This result, thus, is that
which would be expected from a latent infection o f true neurons.

Assessments were carried out to detect the presence of latency-associated
transcripts (LATs). LATs are mRNAs that are ubiquitously found in latently infected
cells (Stevens et al. 1987) but have not been shown to code for proteins. In this way,
LATs are telltale markers of latency. Block et al. used probes to detect LAT RNA via in
situ hybridization in their long-term infected ND-PC12 populations. Probes to the
glycoprotein (g)C transcript, a late gene only transcribed during lytic infection (Deatly et
al. 1987), were also used. The results of these experiments were that gC was not detected
in any cells, but LATs were detected in only 1% of cells. The cells that showed LATs
were those on the periphery of cell clusters. Researchers puzzled over the results o f the
infectious center assay showing 100% o f cells being latently infected while LATs were
only detected in 1%. Even though this finding conflicted with the findings o f LAT
detection in in vivo systems, researchers concluded that the PC 12 system was comparable
to in vivo for studying HSV-1 latency by virtue of similarities in viral DNA structure and
limited transcription (Block et al. 1994).
Jordan, Pepe and Schaffer (1998) utilized the PC 12 cell system for the study of
HSV-1 latency, but did not engineer a quiescent infection. The hypothesis was posed that
some cellular activity substitutes for the transactivation activity of the viral product ICPO.
A product of the IE gene suite, ICPO functions as a broad transactivator o f all other viral
genes during productive infection and also shows activity for other cellular promoters
(Jordan and Schaffer 1997). Using the PC 12 cell model and «212, an HSV-1 deletion
mutant lacking ICPO, the growth factors NGF and fibroblast growth factor (FGF) were
10

tested for the suspected cellular activity that could replace the activity in the ICPOdeficient mutant.

The ICPO-null mutant virus «212 is replication deficient because o f its deletion.
Cells were infected with «212 and wild-type virus KOS for comparison, and then treated
with growth factors. Results showed that NGF and FGF, hormones that induce the
morphological differentiation of PC 12 cells, could increase the amount o f infectious virus
released from cells in both strains of virus, but the effect was some 4-5 times greater in
«212. Epidermal growth factor (EGF), a hormone that induces proliferation in PC 12
cells, did not have significant effects on «212 replication (Jordan Pepe and Schaffer
1998).

NGF had the most profound effect on replication of «212. To better hone in on
what activity was substituting for the absence o f ICPO, kinase inhibitors were used that
could block parts of the NGF-signaling pathway. Inhibitors that could bind more broadly
reduced replication the most, while more specific inhibitors were less effective. None of
the inhibitors were able to completely undo the complementing effect o f NGF in virus
production, though K252a a drug capable of inhibiting most NGF pathways came the
closest to completely blocking the ability o f NGF to bolster «212 replication. Taken
together, these results imply that the ICPO-complementing activity of NGF is due to
multiple branch points in the NGF pathway not just, for example, the result o f an ultimate
transcription factor activation at the very end of the pathway. The authors of this work
suggest that this type of activity demonstrated in the PC 12 line may be similar to the type
of activity that occurs in true neurons and ultimately results in reactivation (Jordan, Pepe
and Schaffer 1998).
11

Danaher, Jacob, and Miller (1999) successfully established a quiescent HSV-1
infection in ND-PC12 cells. Their work first details methods o f cell culturing that would
best reduce the population of dividing PC 12 cells that were not as responsive to NGF as
others, as these cells might serve as reservoirs for a productive infection. To achieve this,
experiments were done to establish that plating cells in serum-free conditions and NGF
only could produce a virtually steady number o f adherent, differentiated cells for seven
weeks.

This group modified the protocol o f Block et al. (1994) with the addition of
acycloguanosine (acyclovir, ACV), an inhibitor o f HSV-1 DNA replication. Wilcox and
Johnson (1988) showed that latency could be induced in sympathetic neurons in tissue
cultured from the superior cervical ganglia o f prenatal rats by the use o f ACV for 10
days. Since ND-PC12 cells have a partial sympathetic neuron phenotype, Danaher, Jacob,
and Miller (1999) thought it appropriate to attempt using ACV.
The result was that after an initial period of productive infection while ACV was
being included in media (10 days post-infection), there was no detectable virus in culture.
This result is in contrast to the work o f Block et al. (1994). Another contrasting finding of
this work was the removal of NGF was not sufficient to reactivate the virus as shown by
Wilcox and Johnson (1988) or increase viral titer as shown by Block et al. (1994).

To confirm the presence of virus in latent form, quiescently infected cultures were
treated with forskolin, a cAMP activator known to reactivate latent HSV-1 (Smith et al.
1992). After 38 and 49 days of maintaining suspected quiescently infected (QIF) PC 12
cultures, forskolin treatments were able to reactivate the virus and produce infectious
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progeny. RT-PCR was also used to detect viral transcripts at different points in the
timeline of the QIF cultures. RT-PCR analysis showed that all transcripts were reduced
by 99% 10 days post-infection (upon ACV-withdrawal) except for the LATs which were
reduced 53%, then remained steady (Danaher, Jacob and Miller 1999).

Another study done by Danaher et al. (1999) presumably in parallel with the
previous work put the QIF-PC12 model to use by experimenting with heat stress as a
stimulus for reactivation. It has been shown that transient hyperthermia, a temporary heat
stress, can lead to FISV-1 reactivation (Halford, Gephart and Carr 1996). QIF-PC12
cultures were grown and established in the same manner and timing as initially done by
Danaher, Jacob, and Miller previously (1999). The ability o f a heat stress at 43°C for one
hour to induce reactivation was compared to forskolin treatment.

In terms of the percentages of cultures that were successfully reactivated by both
forskolin and heat stress, the results were comparable. The main difference seen was that
heat stress could reactivate the virus more quickly than forskolin. Immunocytochemistry
was used to detect viral antigens on the surface o f cells in order to quantify how many
cells had reactivating virus, and it was found that a minority were reactivating (one
immunoreactive focus per 22,000 cells). RT-PCR showed wide scale viral gene induction
among all members tested from each kinetic class as early as 12 hours post-heat stress
(Danaher et al. 1999).

An important finding in this work, aside from the demonstration o f the QIF-PC12
model as a viable means of studying latency, was the confirmation that reactivation due
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to heat stress occurs in a minority o f cells in vitro, as it also does in vivo (Sawtell and
Thompson 1992). It is not discussed what could account for this activity.

After Block et al.’s (1994) initial unsuccessful attempt Su et al. (1999) succeeded
in generating a fully quiescent infection using a different protocol than Danaher, Jacob,
and Miller (1999). Undifferentiated PC 12 cells were seeded onto poly-L-omithine coated
flasks. The medium used was RPMI 1640 supplemented with 10% horse serum and 5%
fetal bovine serum, representing a deviation from the low-serum protocol used by
Danaher, Jacob, and Miller (1999). Furthermore, an antimitotic agent, 5fluorodoxyuridine (5-flu) was included. The initial week of NGF supplementation would
allow for all responsive cells to cease division and differentiation. The inclusion o f 5-flu
at day seven for 2-3 days was thought to eliminate any dividing cells that remained.
Presuming that this technique worked, it would eliminate cells incapable of quiescent
infection upon addition of virus. After this period, 5-flu was discontinued and NGF was
maintained in the serum-supplemented medium. A more significant deviation in this
study that Su et al. claim better represents a naturally simulated latent-like infection was
the decision to exclude the addition o f an anti-viral agent, such as the ACV that Danaher,
Jacob, and Miller (1999) included in their work.
Su et al. (1999) obtained a similar result as Danaher, Jacob, and Miller (1999) in
that there was an initial period of productive infection after addition o f virus to cultures.
Su et al. (1999) reported infectious virus produced for 2-3 days after infection and
speculated that it could be due to the continued presence o f mitotic permissive cells that
were not eliminated by 5-flu, or of some differences among a minority population o f cells
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that would release virus then recover. After this period, there was no detectable virus and
it was reported that the quiescent state had been reached.

To confirm the quiescent state, PCR was done in the thymidine kinase gene of
HSV-1 in order to search for viral genomes. These experiments confirmed that HSV-1
DNA was present in ND-PC12 cells in the flask and plaque assays showed that infectious
virus was not being produced, thus, quiescence had been established. Additionally,
Southern blot hybridization had been performed and LATs were found in all cultures (Su
et al).
To put their own QIF-PC12 model to use, Su et al. (1999) experimented with
introducing subpopulations of different cells into the QIF-PC12 cultures to better
simulate the heterogeneity of an in vivo environment. Human corneal fibroblasts (HCF)
were used because of their ability to support productive infection both in vitro and in
vivo, and also because HCFs are often in contact with the axons o f neurons (Dawson and
Togni 1976; Wander, Centifanto and Kaufman 1980). When HCFs were overlayed onto
QIF-PC12 cells, they moved under the QIF-PC12 cells while the QIF-PC12 cells
maintained their morphology. At this time, NGF was removed from medium. When the
HCFs were added, a productive infection resulted, implying reactivation.
The addition of undifferentiated PC 12 cells and mouse neuroblastomas did not
reactivate the virus. In addition to the HCFs, monkey kidney CV-1 and human
hepatoblastoma HepG2 cells were able to stimulate virus production. Cocultivation under
plaquing conditions demonstrated that reactivation was occurring throughout the QIFPC12 population (Su et al. 1999).
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Superinfection can cause a type o f “domino effect” in which the viral products of
one reactivated cell infect another already quiescently infected cell and stimulate virion
production, resulting in a type of reactivation cascade. Su et al. (2000) generated a
recombinant virus that would produce blue plaques to superinfect already established
QIF-PC12 cells. The reverse process was also carried out whereby wild type virus was
used to infect QIF-PC12 cultures established with recombinant virus. Results showed that
neither strain could be reactivated by superinfection with the other. Also, RT-PCR could
not detect transcripts from any kinetic classes after superinfection indicating that there
was no de novo gene expression after superinfection (Su et al. 2000).

PCR examination of nuclear and cytoplasmic cell fractions showed that most viral
DNA was found in the nucleus, as expected, providing basis for the conclusion that the
lack of reactivation from superinfection is not due to a failure o f the superinfecting viral
DNA to move into the nucleus. When superinfected QIF-PC12 cells were cocultivated
with the HepG2 cells that were shown to induce viral production in QIF-PC12 cells by Su
et al. (1999), both plaque phenotypes could be seen, indicating that the recombinant had
successfully entered the QIF-PC12 and was reactivated just as the wild type was (Su et al.
2000 ).

A significant result of this study was the connection made by the researchers that
the failure of the superinfection to stimulate virus production was more o f a result of the
intracellular environment rather than interference from the existing quiescent viral
genome. Superinfections were carried out 26 days after differentiation had been begun
and maintained, as opposed to the initial infection carried out 10 days after the addition of
NGF. When the researchers differentiated PC 12 cells for 26 days with NGF and then
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began a primary infection, they found similar results as that shown in the superinfection.
That is, instead of an initial productive phase of new progeny, titers instead dropped very
quickly. This was associated with virus that was present in the initial inocula that
persisted through media changes while declining. This implies that the initial period of a
productive infection may be able to be bypassed by differentiating PC 12 cells with NGF
for a longer period of time. This new hypothesis is supported by work in vivo that showed
that neonatal trigeminal ganglia were more permissive to productive infection than adult
trigeminal ganglia when tissue was excised and infected in vitro (Hay, Gaydos and
Tenser 1995). Other previous work supporting this hypothesis showed that ICP4
promoter activity was seen in 100 times more neurons in the trigeminal ganglia of
newborn mice compared to adults (Mitchell 1995). Unfortunately, this was not
investigated further in this study (Su et al. 2000).

In a group comprised of members of the Su et al. study (2000), Moxley et al.
(2002) did work with their QIF-PC12 model that reported a very curious finding. The
report begins with stating that after about seven weeks, ND-PC12 cells detach from
culture substrate. While detachment in cell culturing is widely seen as an indication of
cell death, Moxley et al. (2002) found that the ND-PC12 cells that detached “naturally”
after 37-54 days had viability of 95%, determined by trypan blue assay. QIF-PC12 cells,
however, remained attached for 102 days, the duration of the study.

Moxley et al. (2002) attempted to approach this curious finding from different
angles but were able to gain little insight. They found that LAT null mutants still had the
detachment-preventing effect, indicating that LAT expression was not central to the
prevention of detachment. The two different 17 and McKrae wild type strains were both
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used with the same effect, indicating that the phenomenon is not strain-specific.
Significantly, it was found that viral gene expression was needed in order to facilitate the
phenomenon. This discovery was made by exposing virus to UV, known to render virions
deficient in gene expression and new virion production but not adsorption (Schaffer,
Aron and Bemyesh-Meinick 1973). It was found that ND-PC12 cells infected with
expression-deficient viruses detached by 55 days at rates comparable to uninfected cells,
while infected cells displayed the detachment-prevention phenomenon. One final test
showed that viral DNA replication was not needed for the phenomenon, either, though
this much could have been assumed from knowledge that the virus was in a quiescent
state (Moxley et al. 2002).

There is a paucity of research on the detachment-prevention phenomenon. Related
work in sympathetic and trigeminal neurons has shown that transfection with LATs also
can bolster the survival of neurons when they are deprived o f NGF (Hamza et al. 2007).
The same work showed that LATs also double the regeneration rate of axons and that
these effects are carried out through the mitogen-activated protein kinase (MAPK)
pathway. Clearly, work is being done to elucidate the counterintuitive phenomenon of
viral infection being neuroprotective, but in as much as it applies to the PC 12 system, the
field has been silent.

Miller et al. (2003) returned to QIF-PC12 investigation with the objective to
perform correlative analyses between it and in vivo models. Throughout the history o f the
QIF-PC12 cell model it becomes clear that the teams headed by Block were more
concerned with new information that could come out of the QIF-PC12 model while teams
headed by Miller focused more on establishing the model for its own sake, as an analogy
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of an in vivo latent infection. This 2003 study followed the pattern, where work was done
to compare the QIF-PC12 model to an established rabbit eye model o f ocular herpes and
in vivo latency.

Miller et al. (2003) kept their initial protocols, that is, the inclusion o f ACV and
the lack of an antimitotic agent such as the 5-flu used by the experiments done by the
Block groups. The comparison with the rabbit eye model was carried out by evaluating
the behavior of two viral constructs, 17+/pR20.5/5 which had an immediate-early gene
deletion and 17+/pR20.5/5/LAT which had a LAT ORF in place of the deletion, since it
had been shown that LAT could substitute for the absence of immediate-early activity
(Thomas 1999). As expected, 17+/pR20.5/5 was replication deficient while
17+/pR20.5/5/LAT behaved close to levels o f wild type. The same results were found
when the viruses were reactivated from latency. Miller et al. (2003) then produced their
QIF-PC12 cultures with the viruses and performed the same analyses to both test for the
viability of the QIF-PC12 model and to see if the reactivation phenotypes o f the viruses
would be similar in ND-PC12 neuronal cells. Results showed that viruses demonstrated
the same patterns of reactivation in the QIF-PC12 cultures as they did in the rabbit eyes.
Further data showed that both the in vivo and in vitro models (that is, latently infected
trigeminal ganglia of rabbits and QIF-PC12 cells, respectively) contained comparable
numbers of latent viral genomes respective to each viral construct.

Since the QIF-PC12 cells showed different viral constructs expressing the same
respective reactivation efficiency phenotypes as in the rabbit model, researchers
concluded the QIF-PC12 model was a suitable complement to the in vivo model. The
heterogeneity of other cell types in the in vivo model is both positive and negative: on one
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hand it represents the natural environment that the virus will reactivate in and it is likely
that contact and communication with other cell types plays a role in latency and
reactivation. On the other hand, studying such events and interactions on a cellular and
molecular basis is difficult to do with tissue samples. This is what makes the QIF-PC12
model complementary as opposed to supplementary, in that it does allow for close
cellular and molecular analysis, provided it can be continually shown that the model
behaves similarly to in vivo models. In this analysis, such a demonstration was
successfully done (Miller et al. 2003).

Miller, Danaher, and Jacob (2006) used a number of different mutant viral
constructs with either gene deletions or insertions, and employed recombinant adenovirus
vectors constructed to overexpress different HSV-1 genes with QIF-PC12 cells. The
mutants were as follows: R7910 bearing an ICPO deletion and derived from F strain
(Kawaguchi, Van Sant and Roizman 1997), KD6 bearing an ICP4 deletion and derived
from KOS strain (Dobson et al. 1990), m l 814 bearing a 12-bp insertion that disrupts
VP16’s transactivating domain and derived from 17+ strain, KM 100 a construct virus
derived from both KOS and 17+ containing a mutation rendering ICPO nonfunctional
(same mutation found in mutant n212) and the same VP 16 mutation of m l 814, V422
another VP 16 mutant with the entire C-terminal acidic domain o f VP 16 truncated
(Mossman 1999), and KM 110 bearing both the n212 ICPO mutation and the V422 VP 16
truncation. The genes used in the adenovirus vectors were as follows: origin-binding
protein (OBP), gD, ICPO, ICP4, VP 16, the 2.6 kb LAT, a mutated nonfunctional ICPO,
and a mutated nonfunctional VP 16. For trans expression studies, quiescent infections
were established using strains KOS and 17+ in order to compare differential reactivation
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phenotypes. QIF-PC12 cultures established with each strain were subsequently
superinfected with adenovirus expression vectors. For mutant studies, QIF-PC12 cultures
were then established with the viral constructs and reactivation stressors forskolin, TSA,
or heat stress were used to assess reactivation efficiency from all different strains and
constructs. Reactivation efficiency was measured as # cultures harboring live virus#
total cultures x 100%.

The trans expression studies were used to test the major transcriptional activators,
ICPO, ICP4, and VP 16 to see if overexpression o f any single one could stimulate
reactivation in QIF-PC12 cells. Strain 17+ showed differential reactivation, responding
more efficiently to the ICPO vector than to VP 16 or ICP4. KOS had similar reactivation
after exposure to each vector. Infection with vectors containing OBP (an early gene), gD
(a late gene), LAT, or the mutant ICPO or VP 16 did not induce reactivation above
background levels seen in this study. Results taken together showed that overexpression
of any of the three major transcriptional activators could reactivate the virus in QIF-PC12
cultures, and that there was a stark contrast in the involvement o f ICPO in reactivation
between 17+ and KOS strains, showing a molecular basis for differential reactivation
phenotypes that exist among HSV-1 strains (Miller, Danaher and Jacob 2006).
In mutant studies also done within this work, there was an interesting observation.
The ICPO deletion mutant R7910 reactivated more efficiently in response to forskolin and
heat stress than did its parent F strain. In response to TSA, however, R7910 reactivated
just above basal levels while F strain had greater than 3-fold reactivation efficiency. This
implies a differential pathway of reactivation for TSA than either heat stress or forskolin
treatment. The ICP4 deletion mutant KD6 failed to reactivate after exposure to all
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stresses. When QIF-PC12 cultures created with KD6 were superinfected with the
adenovirus vector expressing ICP4, reactivation did occur. These data together indicate
that ICPO is not required in reactivation from stimuli that apparently work on different
pathways, but ICP4 is an absolute requirement for any type o f reactivation event to occur,
at least at the level for which it could be detected by viral plaque assays. The VP 16
insertion mutant m l814 was then used to establish QIF-PC12 cultures along with its
parent strain 17+. Not only was this mutant able to reactivate following the three stresses,
but another differential reactivation phenotype was seen in that TSA was an efficient
inducer or reactivation in both viruses, approaching nearly 100% efficiency as compared
to the 21% efficiency seen in F strain and 8% in F strain’s derivative R7910 (Miller,
Danaher and Jacob 2006).

Since reactivation was seen in both ICPO deletion and VP 16 mutants, KM 100, a
virus containing both the ICPO deletion and the m l814 VP 16 mutation was used to see
the effect of the absence of both ICPO and VP 16 activities. The result was that
reactivation occurred in response to all stresses, but was most efficient following heat
stress at about 50% reactivation, as compared to forskolin and TSA, both treatments
inducing reactivation in approximately 30% o f cultures (Miller, Danaher and Jacob
2006).
An interesting result was seen with V422, the virus containing a VP 16 whose
acidic C-terminal domain was completely truncated. V422 was not able to reactivate
above the spontaneous levels seen in control cultures in response to the reactivation
stresses. The same result was found using KM 110, a virus containing a mutation in ICPO
and the V422 VP 16 truncated mutation. These results imply that the mutation of VP 16 in
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m l814 does not completely inhibit VP16’s transactivating activity, the acidic C-terminal
domain is required for transactivation in reactivation, and VP 16 itself must be necessary
for stress-induced reactivation (Miller, Danaher and Jacob 2006).

In summary, this study revealed many important details about the interaction of
HSV-1 and ND-PC12 cells: ICPO is not needed in reactivation, ICP4 is essential, and
VP 16 is essential only in stress-induction (Miller, Danaher and Jacob 2006).

Aiamkitsumrit et al. (2007) conducted investigations using a mutant virus within
the context of the QIF-PC12 model. This worked focused on the role that anti-apoptotic
pathways modulated by HSV-1 genes play in infection. The virus used was dl20, derived
from strain KOS, lacking the ICP4 gene and bearing a defective US3 gene (DeLuca,
McCarthy and Schaffer 1985). The US3 gene functions to prevent apoptosis in infected
cells (Benetti, Munger and Roizman 2003; Benetti and Roizman 2004; Jerome et al.
1999) . Virus dl20 defective in US3 has been shown to be very cytotoxic, causing
apoptosis in mitotic cell lines: Vero, SK-N-SH, Hep-2, and HEL (Galvan, Brandimarti
and Roizman 1998; Galvan and Roizman 1999; Leopardi and Roizman 1996; Leopardi,
Van Sant and Roizman 1997; Munger, Chee and Roizman 2001; Zhou and Roizman
2000 ) .

Aiamkitsumrit et al. (2007) sought to determine the extent of involvement of
nuclear factor (NF)-kB in HSV-1 infection o f neurons, and thus used ND-PC12 cells.
Although this work did not explicitly deal with a quiescent infection, the conditions under
which the cells were cultured were identical to those used by Su et al. (1999). The true
goal of maintaining the initial period o f NGF-differentiation in this work, however, was
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not to achieve quiescence but to bypass an initial but transient approximate seven day
period in which it was reported that NF- kB was transiently activated in PC 12 cells after
exposure to NGF (Azoitei, Wirth and Baumann 2005). The interest in NF- kB
involvement stems from a previous hypothesis that NF- kB could allow for viral DNA
replication (Amici et al. 2004, Gregory et al. 2004, et al. Patel 1998) and demonstrations
that NF- kB could possibly be involved in pro- or anti-apoptotic pathways (Goodkin, Ting
and Blaho 2003; Taddeo et al. 2003; 2004; Yedowtiz and Blaho 2005).

Since the previous studies were only done on dividing cells, Aiamkitsumrit et al.
(2007) experimented with ND-PC12 cells to see how dl20 behaved. The first observation
noted was that, just as seen by Su et al. in 2002, infection with dl20 prevented the
detachment of cells from culture flasks. A difference was seen in the duration of
detachment in that dl20-infected cells detached earlier than wild-type KOS-infected
cells. Nearly 100% of KOS-infected cells remained attached at day 45 as compared to
approximately 50% if dl20-infected cells seen at the same time. Cells infected with dl20
still remained attached for longer than uninfected cells.
It was also seen that dl20 failed to induce apoptosis in ND-PC12 cells. Parallel
infections were carried out with Vero cells and confirmation of apoptosis as a result of
infection was seen (Aiamkitsumrit et al. 2007).
In assessing for the involvement o f NF- kB in dl20-mediated apoptosis, Western
blotting of cytoplasmic and nuclear cell fractions was carried out on p65. Even though
p65 was confirmed to be present in the ND-PC12 cells, infection by both KOS and dl20
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did not show its translocation from cytosol to nucleus, indicating a failure to activate the
NF- kB pathway (Fuseler et al. 2006).

The report was the first to demonstrate a failure of d 120 to cause apoptosis in a
cell line. This finding paired with the group’s earlier finding demonstrating that linear
viral DNA has a much higher half-life in ND-PC12 cells than it does in dividing cells (30
days in ND-PC12 vs. 3 days in dividing cells; Su et al. 2002).
Danaher et al. (2008) sought to perform microarray analysis on QIF-PC12 cells to
determine differences in gene expression as compared to mock infected cells. Results
were validated with real-time PCR. A total number o f 9,064 genes o f R. norvegicus were
analyzed with 1,427 being significantly altered in expression by quiescent infection.
Those that were most upregulated (greater than 3-fold) were KEGG pathways that were
significantly associated with QIF-activated genes (ranged from 1.13- to 2.15-fold
upregulated), genes involved in significant molecular functions (ranged from 1.59- to
6.51-fold upregulated), and genes that were at least 50% repressed (ranged from to 0.29to 0.50-fold downregulated). Results showed only few patterns. Genes that were most
upregulated by quiescent infection were those involved in proteolysis and in
collagen/axonal remodeling. Expectedly, genes that were most downregulated were those
involved in apoptosis, as well as ion transport and cGMP biosynthesis.

The PC 12 cell system represents a viable alternative to tissue explant models in
studying latency. When parallel in vivo studies were undertaken, data derived from
experiments with tissue expiants were very similar to that o f the PC 12 in vitro system.
PC 12 cells provide for a readily replenishable and homogeneous source of cultured cells
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that are appropriate for neuronal studies. However, it must still be considered that
differences among neuronal phenotypes may produce misleading results. NGF and its
signaling pathways may be the cornerstones in validating the PC 12 model, linking the
sympathetic neuronal phenotype to the sensory neuronal phenotype.

The highlight of the QIF-PC12 model is that virus can be reactivated and
recovered by stimuli known to reactivate virus in vivo. It would be difficult to suggest
that the molecular events that transpire as a result are very different in sympathetic
neurons than in sensory neurons, but this possibility cannot be ruled out.

When latency is examined in the context o f the PC 12 system, there is an overall
lack of experimentation with small molecule drugs. The convenience o f the QIF-PC12
system will allow for the use of inhibitor drugs to better study enzymatic events in the
switch from latency to reactivation. Among the many foreseeable applications of a
successful HSV-1 latency model, one of them is the possible mediation o f latency and
reactivation through small molecule inhibitors. The conundrum posed by HSV-1 is that it
is a lifelong infection in neurons. Inducing wide-scale apoptosis o f infected neurons by
either using a Double-stranded RNA [dsRNA] Activated Caspase Oligomerizer
(DRACO) (Rider et al. 2011) or inducing the immune system to recognize and attack
latently infected cells may solve the infection problem but result in undesirable loss o f a
largely non-dividing cell population that could lead to a clinical loss o f sensation. Normal
antiviral drug therapies may succeed in reducing, but not eliminating reactivation events,
yet spare the host cells of destruction. The best approach may be one that has a longer
and wider scope of focus, specifically in finding better inhibitors o f reactivation in the
presence of reactivation stimuli for use at the patient level, followed by a robust and
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vigilant public health initiative at the population level that will reduce the number of
infections in succeeding generations. Herpesviruses in general are widely accepted as
having coevolved with humans very successfully. Overcoming such challenges requires
that humans implement knowledge from multiple levels o f disease understanding.
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METHODS and MATERIALS

Virus and Cells

Adherent rat pheochromocytoma (PC 12) cells and African green monkey kidney (Vero)
cells were acquired from ATCC, Manassss, VA (Adh-PC12 Cat# CRL-1721.1; Vero
Cat# CCL-81). PC 12 cells were propagated in DMEM containing 10% horse serum (HS)
and 5% fetal bovine serum (FBS) in tissue culture treated flasks. Vero cells were
propagated in DMEM containing 5% FBS in tissue cultured treated flasks. All media
were supplemented with gentamicin at 100 pg/ml. Cells were incubated at 37°C and 7.5%
CO 2 . PC 12 cells were scraped and split 1:4 every 3 days. Vero cells were trypsinized and
split 1:5 every 5 days. Virus GHSV-UL46 was purchased from ATCC, Manassas, VA
(VR-1544). Viral stocks were prepared by passaging through Vero cells and then stored
in -80 °C.

PC 12 Differentiation

PC 12 cells were seeded on collagen I-coated 24-well plates at a density o f 29,000
cells/cm2 in DMEM containing 1% HS and 0.5% FBS. Cells were allowed 24 hours to
attach. Mouse 2.5S nerve growth factor (NGF) (Becton Dickinson, cat# 356004) was
subsequently added to media at 100 ng/ml. Media was changed every 3 days thereafter
and henceforth included NGF. On day 7 post-plating, the anti-mitotic 5fluorodeoxyuridine (5-flu) was added at a concentration of 20 pM to eliminate cells not
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responsive to NGF. 5-flu was discontinued thereafter. Differentiation was confirmed by
microscopic visualization of neurite outgrowths.

Reagents

On Day 10 post-plating, the following reagents were included in media replenishments:
acycloguanosine (acyclovir, ACV)(Sigma-Aldrich CAS# 59277-89-3) at 100 pM,
roscovitine (Rosco)(SelleckBio, cat #S 1153) at 100 pM, PD98059 (PD)(SelleckBio cat#
SI 177) at 20 pM, or a combination rosco 100 pM + PD 20 pM treatment. Reagents were
maintained in media atevery replenishment thereafter. Phosphate-buffered saline (PBS)
(Sigma-Aldrich P4593) was diluted from lOx stock provided down to lx (.01M
phosphate buffer, .0154M sodium chloride) and supplemented with gentamicin at 100
pg/ml.

ND-PC12 Infection
Eleven days post-plating, infection using GHSV-UL46 at MOI 3 was carried out by first
aspirating all media then adding 100 pi o f virus to each well on a 24-well plate. Plates
were incubated for 1 hour at 37°C with intermittent rocking o f plates every 15 minutes.
Excess virus was then aspirated and fresh media containing reagents was added.

Vero monolayer infection

For all instances of infections using Vero cell monolayers, Vero cells were propagated in
tissue culture-treated 6-well plates and maintained as described. Upon reaching
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confluence, media were aspirated. For inhibitor studies using Vero cells, 500 pL o f viral
stock was added to each well of 6-well plates. For assessment of viral presence in NDPC12 cultures, 500 pL of ND-PC12 media from cultures was added to each well o f Vero
cells. After the addition of stock/media, plates were incubated in 37°C and 7.5% CO 2 for
1 hour with intermittent rocking of plates every 15 minutes. Excess virus/media were
aspirated, fresh Vero media were added, and cells were incubated at 37°C and 7.5% CO 2
for 48 hours, after which point apoptosis and cytopathic effect were assessed for visually.

Fluorescence microscopy

Analysis of cultures and detection o f EGFP was carried out using a Motic AE30/31
fluorescence microscope set to FITC with a 494 nm excitation wavelength and a 518 nm
emission wavelength. Images were recorded using a digital microscope ocular camera
with USB data transfer to an HP Pavillion laptop.

Cell culture stresses
Combination heat and starvation stresses were carried out concurrently by first replacing
media of infected ND-PC12 cultures with PBS. No sera, nutrients, or other growth factors
were added. Inhibitor drugs were maintained in respective cultures. After replacing with
PBS, cultures were incubated at 41°C, 7.5% CO 2 for 24 hours. After the 24 hour period of
heat stress, cultures were transferred to a 37°C incubator, 7.5% CO 2 , and remained in PBS
without change or replenishment.
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RESULTS

The ICPO activity inhibitor Rosco was assessed for its ability impact latency of
GHSV-UL46 in ND-PC12 cells. It has been shown that inhibition o f cdk5 via Rosco
causes apoptosis in cortical neurons and slows/lessens the phenotypic differentiation of
PC 12 cells by NGF via sustained overactivity o f MEK1 (Zheng et al. 2007). A specific
MEK1 inhibitor, PD98059 (PD), was shown to rescue neurons from the detrimental
effects of Rosco (Zheng et al. 2007). Rosco and PD were added individually or together
to ND-PC12 cells or Vero cells 1 day prior to infection (11 days post-plating and NGFdifferentiation for PC 12 cells). ACV was added for comparison.

Vero cells were infected with GHSV-UL46 at an MOI o f 3 in the presence of
inhibitors. After 48 hours, direct microscopic examination of cultures for cytopathic
effect (CPE) was carried out using an inverted microscope. After the addition o f GHSVUL46, CPE was seen in virtually 100% o f cells without inhibitor treatments (Figure 1A).
Treatments o f Vero cells with ACV showed virtually complete protection from CPE and
the maintenance of a confluent monolayer (Figure IB). The individual addition o f both
inhibitors, Rosco and PD, showed a differential effect on cell cultures. Rosco-treated
cultures showed more CPE as compared to ACV-treated cultures, but less than untreated
cultures as roughly 5-10% of cells remained attached (Figure 1C). PD did not appear to
have any effect on Vero cultures (Figure ID) and is comparable to the result seen in
Figure 1A with no treatments added. The combination treatments of Rosco and PD
(Figure IE) showed results similar to those seen with the singular addition o f Rosco.
Figure IF is included as an NGF control to show it has no antiviral effect. All inhibitors

31

were added to parallel cultures of uninfected Vero cells to screen for unexpected
detachment from substrate; none was seen (Figure 1).

Figure 1. Inverted microscope images of Vero cells 72 hours after infection with GHSV-UL46,100X. A.) No treatment
B.) ACV C.) Rosco D.) PD E.) Rosco + PD F.) NGF
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ND-PC12 cells were differentiated as previously described and infected at MOI of
3. One day prior to infection, inhibitors were included in media and for every
replenishment thereafter. Seven days after infection, assessment of viral production was
made using fluorescence microscopy and inoculation o f Vero monolayers with infected
ND-PC12 media using Vero apoptosis as positive confirmation of the presence of
infectious virus.

Figure 2 shows the results o f fluorescence imaging. Undifferentiated PC 12 cells
did not thrive in low-serum medium and persisted at low numbers in culture (Figure 2A).
Uninfected ND-PC12 cells thrived under low-serum conditions supplemented with NGF
(Figure 2B). In concordance with earlier work done on the QIF-PC12 model,
differentiation with NGF resulted in an approximately 40-50% decrease in cell number
followed by a period in which cell number was maintained (Block et al. 1994).
Unexpectedly, fluorescence was still seen where ACV was added, as well as Rosco
(Figures 2D and 2E, respectively). When PD was included as the only treatment, no
visible fluorescence was observed (Figure 2F). The combination treatment o f Rosco and
PD showed a return to fluorescence, but less noticeable than all other positive results.
(Figure 2E). When media from infected ND-PC12 as well as Vero cultures was used to
inoculate Vero cell monolayers, data obtained correlated directly with results obtained
from inverted and fluorescence microscope imagery with the exception o f the culture
subjected to PD that did not show fluorescence (Figure 2F). A summary o f the combined
results seen is presented (Table 1, Figure 2).

Figure 2. Fluorescence microscope pictures taken 10 days post-infection (All 100X, except 2B. 400X ) A.)
Undifferentiated, uninfected PC 12 cells B.) Uninfected ND -PC 12 cells C.) Infected ND-PC12 cells,
untreated

D .) ACV-treated infected N D -PC12 cells E.) Rosco-treated infected N D -PC12 cells F.) PD-

treated infected ND-PC12 cells G.) Rosco+PD-treated infected N D -PC12 cells
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T re a tm e n t

N D -P C 1 2

V e ro

M ock

♦

+

ACV

♦

*

Bosco

*

+

PD

■f

Bosco+P D

+

Table 1. Media from indicated cell cultures subjected to treatments tested on Vero cell monolayers; positive
or negative for presence o f infectious virus by detection o f CPE in Vero cells.

It has been repeatedly seen that a productive infection results for at least 10 days
after infection with HSV-1 in ND-PC12 cells (Block et al. 1994; Danaher, Jacob and
Miller 1999). This was the case with GHSV-UL46 as well, as evidenced by using lysate
to inoculate monolayers of Vero cells and monitoring for CPE as positive confirmation of
virus presence. After 10 days, it was still seen that all ND-PC12 cultures were still
producing virus. Since it has been previously shown that some, but not all, wild-type
HSV-1 infected ND-PC12 cells do undergo low-level spontaneous reactivation
throughout the infectious cycle (Danaher et al. 1999) and that on some occasions, lowlevel activity continues indefinitely (Block et al. 1994), environmental stressors were
applied despite the absence of a truly quiescent infection due to their ability to increase
virus production regardless of the state o f infection (Block et al. 1994; Danaher et al.
1999). Heat stress and NGF-deprivation have been individually shown to reactivate a
high number of QIF-PC12 cultures (Danaher et al. 1999, Block et al. 1994, respectively),
and NGF was seen to be inhibitory to reactivation (Feib et al. 1991). The heat stress used
in the referenced work was carried out at 43° C for 3 hours. For this study, the heat stress
was tempered down to 41°C and lengthened in duration to 24 hours. These criteria were
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used to better simulate the febrile conditions that are widely known to reactivate herpes
simplex viruses in clinical situations (Epstein 1941), which presumably led earlier
medical professionals to term the telltale herpetic skin lesions “fever blisters.” Since it
has already been shown that a different ICP4 deletion mutant, KD6, did not reactivate
after heat stress, and that differential pathways o f reactivation may exist that respond to
different types of stimuli (Miller, Danaher and Jacob 2006), the second reactivation
stimulus was included in the form of nutrient- and NGF-deprivation through complete
starvation of cultures of both sera and media. Applying both these stresses
simultaneously was used to test for a synergistic activation o f differential reactivation
pathways.

In the case of uninfected ND-PC12 cells, 24 hours of heat stress under starvation
conditions produced the expected result o f complete detachment from culture wells
(Figure 3A). Figure 3A is a representative image of untreated, uninfected cells, but in all
other cases in which uninfected cells were subjected to treatments, the results of
detachment of all cells and loss of neural morphology were the same. However, in all
cultures that had been previously exposed to GHSV-UL46, attached cells persisted
regardless of treatment applied or withheld (Figures 3B-3F). Differences in morphology
can be seen in Rosco treated infected cells (Figure 3D), consistent with the previously
documented loss of morphology ND-PC12 cells experience after long-term exposure to
Rosco (Zheng et al. 2007), but ND-PC12 cells still remained attached. There was a
notable decrease in cell density (~40-50%) and detached cells were present, but a large
number of attached, intact cells remained. Densities of infected cell cultures post-heat
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stress (Figure 3) can be compared to those o f pre-heat stress uninfected and infected cell
cultures previously shown (Figure 2B and 2C, respectively, Figure 3).

Figure 3. Inverted m icroscope images o f ND-PC12 cells after 24 hour heat stress. A.) Uninfected, untreated
cells B.) Infected, untreated cells C.) ACV treated infected cells D .) R osco treated infected cells E.) PD
treated infected cells F.) Rosco+PD treated infected cells

Post-heat stress virion production was tested for by once again transferring lysates
from infected ND-PC12 cultures to monolayers o f Vero cells. CPE was seen in all
cultures o f Vero cells exposed to lysates, though not to the extent as seen in Figure 1A
where a known MOI o f 3 was used to infect. These results are identical to those obtained
prior to heat stress.
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DISCUSSION
The purpose of this study was to examine the suggestion made by Liu et al.
(2010) that a repressor/anti-repressor relationship may exist between the viral products
ICPO and ICP4 and that this relationship may have significant implications for latency.
Small molecule inhibitors were used in order to narrow the field o f possibilities for the
molecular events that take place. Data gained from the use of inhibitors implicate host
cell cdk’s and members of the MAPK pathway as potentially significant players in the
molecular events that mediate the switch from latent to productive infection and vice
versa.

Data indicates that a quiescent infection did not take place during the course of
this study. The previous work done on establishing a QIF-PC12 model shows that one of
two outcomes can result from infecting ND-PC12 cells with HSV-1: 1.) a quiescent state
devoid of new virion production and lowered gene expression, save for spontaneous
reactivation (Danaher, Jacob and Miller 1999) or 2.) a low-level, long-term productive
infection (Block et al. 1994). The use o f ACV, an inhibitor of the viral thymidine kinase,
has been shown to be an optional addition in the establishment of the quiescent infection
and not necessary (Su et al. 1999).

ACV was shown to be a potent inhibitor o f viral productive infection in Vero
cells, where minimal CPE was seen as a result o f infection from GHSV-UL46 (Figure
IB). Images taken from a light microscope o f the infected Vero cells treated with ACV
do show some detached cells. This could be as a result of naturally-occurring cell
detachment during the incubation period as cell density nears confluence, or due to a less
than 100% inhibition of viral replication by ACV. The latter possibility is considered
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more likely and more consistent with the imagery. Identical conditions o f infection and
ACV treatment in ND-PC12 cells showed a low-level productive infection inferred by
fluorescent activity seen via fluorescence microscope imagery (Figure 2D). It is
important to note that the fluorescence is mostly seen in the center o f cell clusters. Such
close clustering of cells may have prevented adequate diffusion o f ACV into cells in the
center of the cluster and caused a failure to prevent viral replication. To support this
reasoning, fluorescent activity can be seen more uniformly throughout untreated infected
ND-PC12 cells irrespective of differential cell density (Figure 2C).

Similar contradictory results between Vero and ND-PC12 cells were seen when
Rosco was used as a treatment. Rosco appeared to have a small protective effect on Vero
cells (Figure 1C) but did not impact the establishment of latency o f induction of
reactivation in ND-PC12 cells as evidenced by fluorescence seen in cells (Figure 3E) and
infection of Vero cells induced by lysates (Table 1). One explanation for this may be that
NGF affects the promoters of HSV-1 IE genes. In HSV-1 infected ND-PC12 cells
displaying a low-level productive infection, NGF upregulates ICPO 4-fold (Block et al.
1994). The concentration of Rosco used in this study was 100 pM, based on previous
work that showed this concentration as adequate for inhibition of ICPO activity in
dividing cells not known to be responsive to NGF (Davido, Leib and Schaffer 2002). If
ICPO levels are quadrupled in NGF-responsive cells as suggested by Block et al. (1994),
then this concentration of Rosco may be insufficient to inhibit ICPO activity. Since long
term exposure to the 100 pM Rosco concentration is detrimental to ND-PC12 cells
without the aid of PD (Zheng et al. 2007), a corresponding 4-fold increase in Rosco
concentration to match the upregulated levels o f ICPO may contribute additional
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challenges, however, combinations o f Rosco and PD should be experimented with further
to assess for the specific likelihood o f this outcome.

The possibility that the levels of Rosco used in this study were overwhelmed by
NGF-stimulated ICPO activity is further supported. In work done with ICPO deletion
mutants infecting ND-PC12 cells, NGF was seen to have an ICPO-complementing ability
sufficient enough to return new virion production in cells infected by ICPO mutants to
near-wild type levels (Jordan, Pepe and Schaffer 1998). The combination of NG F’s ICPOcomplementing activity as well as its ability to upregulate ICPO itself may have more
than overwhelmed any inhibitory effect Rosco was having within the ICPO pathway.
However, if it can be shown that Rosco concentrations can be safely increased with the
help of PD, valuable information could be obtained on the ICPO pathway. If using Rosco
does not halt or hinder production o f new viral proteins, it would be reasonable to
conclude that the mechanism by which NGF complements ICPO is not the mechanism by
which Rosco enacts its inhibitory effects, namely, the phosphorylation of an ICPO-like
signaling protein or transcription factor by cdk5. Cdk5 could thusly be ruled out as a
major player in the ICPO pathway inasmuch as it applies to latency.
As mentioned, PD was included as a prophylactic treatment to mitigate the loss of
neural morphology of ND-PC12 cells after exposure to Rosco. PD is a highly specific
inhibitor of MEK1 and, to a lesser extent, MEK2 (Sharma et al. 2002). At the outset of
NGF-stimulated differentiation of PC12 cells, MEK1 is required for the initiation of
neurite outgrowth, but is active for only a short period o f time (1-2 hours) until cdk5
levels rise (Sharma et al. 2002). The phosphorylation o f MEK1 by cdk5 inactivates
MEK1 and allows ND-PC12 cells to survive in a non-mitotic state while maintaining
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neural morphology (Zheng et al. 2007). Visual inspection o f neuritic outgrowth across
ND-PC12 cultures showed the expected difference among cultures treated with Rosco
alone vs. Rosco and PD together.

Unexpectedly, PD controls showed the most contrasting results. The effects o f PD
with or without Rosco showed the greatest difference with little to no fluorescence in
ND-PC12 cells (Figures 2F and 2G) but no protection from CPE in Vero cells (Figure
ID). The positive confirmation of virus in PD-treated cultures seen from infecting Vero
monolayers with lysates could have been due to residual virus, or a level of infection too
low for fluorescent detection yet sufficient enough to produce infectious virions. In the
ICPO deletion mutant studies previously mentioned, it was seen that treatment with PD
negated approximately 50% of the NGF-complemented stimulation of the virus (Jordan,
Pepe and Schaffer 1998). It is possible that PD may partially negate the NGF-stimulated
upregulation of ICPO, enough to shift equilibrium towards latency and produce the results
shown here. However, the results of experiments done with combination Rosco and PD
treatments still show low-level virus activity; albeit at a lower degree than other cultures
(Figure 3G). One possible implication is that the effects o f Rosco and PD are antagonistic
to each other. The previously referenced report of PD negating the NGF-complemented
replication of ICPO by only 50% demonstrates that other pathways exist that either work
additively or synergistically to fully complement ICPO activity. Indeed, it was shown that
the broader the spectrum of kinase inhibition that a drug could achieve, the more negation
that was seen. Since the use of Rosco would not only inhibit cdk5, but also cdkl and
cdk2 (Meijer et al. 1997), it may be o f value to consider that the effects of inhibition of
these kinases may work to promote viral replication in non-mitotic cells.
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The low level inhibition of viral replication by Rosco in Vero cells may imply a
degree dependence on cdkl, cdk2, or cd5 during a fully productive infection. This
dependence could be thought to be an identically persisting factor during infection in
ND-PC12 cells, but the results of the Rosco and PD combination treatments would imply
otherwise. Treatment with PD appears to halt a low-level productive infection in NDPC12 cells to the point of non-detection by fluorescence, but has no effect during a fully
productive infection in Vero cells. Differential activity o f MEK1 and possibly MEK2 is
suggested by these findings. The substrates acted upon by MEK1 and MEK2 could prove
to be very valuable candidates for future investigations into latency and reactivation in
neuronal cells. A suitable starting candidate may be found in MYC, a downstream
transcription factor in the MAPK pathway (Nagai et al. 1997) that has been shown to be
upregulated 2.57 times more in QIF-PC12 cells than uninfected ND-PC12 cells (Danaher
et al. 2008).

The restoration to low-level productivity when Rosco and PD are used
simultaneously suggests that the roles o f ckdl, cdk2, and/or cdk5 may be different during
infection in ND-PC12 cells versus Vero cells. ICPO has 11 different phosphorylation sites
phosphorylated either by HSV-1 ’s own UL13 or host kinases (Davido et al. 2005). It is
possible that the activity of ICPO can be finely adjusted by different combinations of
phosphorylation in such a way as to not only affect ICPO’s transactivating activity, but
also its potential to bind other proteins such as ICP4. Interestingly, the expression
analysis carried out in QIF-PC12 cells showed that among the genes most repressed by
an FISV-1 quiescent infection was cyclin-dependent kinase inhibitor IB (CDKN1B;
Danaher et al. 2008), whose product binds to and inhibits the activity o f cdk2 and cdk4

42

(Polyak et al. 1994). It was found to be repressed to a level of 0.69 o f that found in
parallel uninfected ND-PC12 cultures (Danaher et al. 2008). Additionally, ICPO has been
shown to bind cyclin D3 and in this way inactivate cdk4 and cdk6 (Kalamvoki and
Roizman 2009). Taken together these data could imply that HSV-1 achieves its own
manipulation, monitoring, and control o f its life cycle by downregulating certain host
processes in order to make its own processes more sensitive to stimuli.

In the context of the ICP0-ICP4 hypothesis, the findings shown here may suggest
that inhibition of ICPO activity by preventing its phosphorylation by cdkl, cdk2, and
cdk5 does not substitute for the suggested downregulation o f ICPO by ICP4 since it did
not produce a quiescent infection. Since a quiescent infection was not achieved, the
ability for GHSV-UL46 to reactivate in the presence of different inhibitors could not be
tested. Since Rosco inhibits the phosphorylation of ICPO in a very specific way, it is
unknown if other phosphorylation events go on that go towards or against the
establishment of quiescence. Because ICPO is still present in the cell at normal or higher
levels, the possibility that it complexes with other proteins and enacts other effects when
doing so still remains.
While it has been documented in the past that infection with different strains of
HSV-1, including dl20 from which GHSV-UL46 is directly derived, results in a
protective effect on ND-PC12 cells in the form of preservation o f neural morphology and
prevention of detachment from culture flasks (Aiamkitsumrit et al. 2007; Moxley et al.
2002), this is the first report showing that the extreme conditions o f prolonged heat stress
coinciding with complete starvation o f sera and nutrients did not abate this protective
effect. Cultures of uninfected cells, regardless o f presence or absence o f any treatments,
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were virtually all detached from culture wells upon viewing, 24 hours after heat stress. A
very small minority of loosely attached cells showed cytopathy and a complete loss of
neural morphology (Figure 3A). The only difference among infected cultures after heat
stress was that Rosco-treated cultures showed a slight decrease in neural morphology, as
expected (Figure 3D). Positive confirmation of virus presence was seen in all cultures by
infection of Vero monolayers with ND-PC12 lysates.

The methodology shown here o f using a fluorescent virus that is only visualized
during a productive infection and a convenient neuronal-like cell model is suitable for the
study of latency in HSV-1. A key component to this design is the EGFP attached to the
tegument protein of GHSV-UL46. That quality renders the virus ideal for the study of
latency, since fluorescence necessarily implies a productive infection. The PC 12 model
provides renewable and homogeneous source of cells for which to study either a lowlevel productive or quiescent infection. The results shown here demonstrate that there are
clear differences in responses to inhibitors in the contexts o f fully productive and lowlevel productive infections. The use o f small molecule inhibitors is a convenient way to
find suitable molecular candidates for future investigation, especially significant in
elucidating the molecular events of latency and reactivation. Future explorations using
this experimental model would greatly benefit from the inclusion o f fluorescent plate
reading technology. Measuring fluorescence in addition to viewing it would provide for
an objective method of quantifying viral productivity, latency, and reactivation. Numbers
garnered from plate reader data could then be correlated to viral titers, and patterns then
examined. The unique benefit of using GHSV-UL46 with the PC 12 model could be
capitalized by the engineering of a strain of quiescently infected, undifferentiated (and
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thus actively dividing) PC 12 cells similar to the NC37 strain o f human cord blood
lymphocytes that are latently infected with Esptein-Barr virus (Fresen et al. 1980).
Although one group has reported that the removal o f NGF from media increases virion
production during a low-level productive infection in ND-PC12 cells (Block et al. 1994),
work has also been done showing that removing NGF from media of true QIF-PC12 cell
cultures does not result in reactivation (Danaher, Jacob, and Miller 1999), and it is known
that ND-PC12 cells reverse their phenotypes and dedifferentiate back into mitotic form
after prolonged NGF deprivation (Greene and Tischler 1976). Furthermore, since ICP4
mutants have been shown to fail to reactivate (Miller, Danager and Jacob 2006),
engineering such a PC 12 strain using GHSV-UL46 may also reveal more mechanisms of
latency and reactivation. Whether a quiescently infected, dividing strain o f PC 12 cells
could be achieved or not, the results of such an endeavor would certainly be rewarding.

45

BIBLIOGRAPHY
Advani SJ, Hagglund R, Weichselbaum R, Roizman B. 2001. Posttranslational dd
processing of infected cell proteins 0 and 4 o f herpes simplex virus 1 is sequential and
reflects the subcellular compartment in which the proteins localize. J. Virol. 75:79047912.
Aiamkitsumrit B, Zhang X, Block TM, Norton P, Fraser NW, Su Y. 2007. Herpes
simplex virus type 1 ICP4 deletion mutant virus dl20 infection failed to induce apoptosis
in nerve growth factor-differentiated PC12 cells. JNeuroVirol 13: 305-314.
Amici C, Belardo G, Rozera C, Bernasconi D, Santoro MG. 2004. Inhibition of
herpesvirus-induced HIV-1 replication by cyclopentanone prostaglandins: role of
I [kappa] B kinase [IKK]. AIDS 18: 1271-1280.
Azoitei N, Wirth T, Baumann B. 2005. Activation o f the IKappaB kinase complex is
sufficient for neuronal differentiation o f PC 12 cells. J Neurochem 93: 1487-1501.
Batterson, W., and B. Roizman. 1983. Characterization o f the herpes simplex virionassociated factor responsible for the induction o f alpha genes. J. Virol. 46:371-377.
Benetti, L, Munger J, Roizman B. 2003. The herpes simplex virus 1 US3 protein kinase
blocks caspase-dependent double cleavage and activation of the proapoptotic protein
BAD. J Virol. 77:6567-6573.
B enetti:, Roizman L. 2004. Herpes simplex virus protein kinase US3 activates and
functionally overlaps protein kinase A to block apoptosis. Proc. Natl. Acad. Sci. U. S. A
101: 9411-9416.
Block T, Barney S, Masonis J, Maggioncalda J, Valyi-Nagy T, Fraser FW. 1994. Long
term herpes simplex virus type 1 infection o f nerve growth factor-treated PC 12 cells. J
Gen Virol 75:2481-2487.
Cai W, Schaffer PA. 1991. A cellular function can enhance gene expression and plating
efficiency of a mutant defective in the gene for ICP0, a transactivating protein o f herpes
simplex virus type 1. J Virol. 65: 4078^1090.
46

Campbell, M. E., J. W. Palfreyman, and C. M. Preston. 1984. Identification of herpes
simplex virus DNA sequences which encode a trans-acting polypeptide responsible for
stimulation of immediate early transcription. J. Mol. Biol. 180:1-19.
Chen SH, Lee LY, Garber DA, Schaffer PA, Knipe DM, Coen DM. 2002. Neither LAT
nor open reading frame P mutations increase expression of spliced or intron-containing
ICPO transcripts in mouse ganglia latently infected with herpes simplex virus. J Virol 76:
4764^1772.
Cook, M.J., Bastone, V.B., and Stevens, J.B. 1974. Evidence that most neurons harbor
latent herpes simplex virus. Infection and Immunity. 9:945-951.
Danaher RJ, Jacob RJ, Chorak MD, Freeman CS, Miller CS. 1999. Heat stress activates
production of herpes simplex virus type 1 from quiescently infected neurally differentiate
PC12 cells. JNeuroVirol 5: 374-383.
Danaher RJ, Jacob RJ, Miller CS. 1999. Establishment o f a quiescent herpes simplex
virus type 1 infection in neurally-differentiated PC 12 cells. J NeuroVirol 5: 258-267.
Danaher RJ, McGarrel BS, Stromberg AJ, Miller CS. 2008. Herpes simplex virus type 1
modulates cellular gene expression during quiescent infection o f neuronal cells. Arch
Virol 153: 1335-1345.
Davido DJ, Leib DA, Schaffer PA. 2002. The cyclin-dependent kinase inhibitor
roscovitine inhibits the transactivating activity and alters the posttranslational
modification of herpes simplex virus type 1 ICPO. J Virol 76: 1077-1088.
Davido DJ, von Zagorski WF, Lane WS, Schaffer PA. 2005. Phosphorylation site
mutations affect herpes simplex virus type 1 ICPO function. J Virol 79: 1232-1243.
Dawson CR, Togni B. 1976. Herpes simplex eye infections: clinical manifestations,
pathogenesis and management. Surv Opthalmol 21: 121.
Deatly, A.M., Spivack, J.G., Lavi, E., Fraser, N.W. 1987. RNA from an immediate early
region of the HSV-1 genome is present in trigeminal ganglia o f latently infected mice.
Proc. Natl. Acad. Sei. USA 84: 3204-3208.
47

Dobson AT, Margolis TP, Sederati F, Stevens JG, Feldman LT. 1990. A latent,
nonpathogenic HSV-1 derived vector stably expresses beta-galactosidase in mouse
neurons. Neuron 5: 353-360.
DeLucaNA, McCarthy A, Schaeffer PA. 1985. Isolation and characterization o f deletion
mutants of herpes simplex virus type lin the gene encoding immediate-early regulatory
protein ICP4. J Virol 56: 558-570.
Efstathiou S, Minson AC, Field HS, Anderson JR, Wildy P. 1986. Detection o f herpes
simplex virus-specific DNA sequences in latently infected mice and in humans. J Virol
57: 446-455.
Epstein NN 1941. Herpes simplex following artificial fever therapy. J Am Med Assoc
117:1327-1330.
Everett RD. 1984, Trans activation o f transcription by herpes virus products: requirement
for two HSV-1 immediate-early polypeptides for maximum activity. EMBO J 3: 31353141.
Frazier DP, Cox D, Godshalk EM, Schaeffer PA. 1996. The herpes simplex virus type 1
latency-associated transcript promoter is activated through ras and raf by nerve growth
factor and sodium butyrate in PC 12 cells. J Virol 70: 7424-7432.
Frazier DP, Cox D, Godshalk EM, Schaeffer PA. 1996a. Identification o f cA-acting
sequences in the promoter of the herpes simplex virus type 1 latency-associated
transcripts required for activation by nerve growth factor and sodium butyrate in PC 12
cells.
Fresen KO, Cho MS, Gissman L, zur Hausen H. 1980. NC37-R1 Epstein-Barr virus
(EBV): a possible recombinant between intracellular NC37 viral DNA and superinfecting
P3HR-1 EBV. Intervirology 12: 303-310.
Fuseler JW, Merril DM, Rogers JA, Grisham MB, W olf RE. 2006. Analysis and
quantification of NF-[kappa]B nuclear translocation in tumor necrosis factor alpha (TNF[alpha]) active vascular endothelial cells. Microsco Microanal 12: 269-276.

48

Galvan V, Brandimarti R, Roizman B. 1999. Herpes simplex virus 1 blocks caspase-3independent and caspase-dependent pathways to cell death. J Virol 73: 3219-3226.
Galvan V, Roizman B. 1998. Herpes simplex virus 1 induces and blocks apoptosis at
multiple steps during infection and protects cells from exogenous inducers in a cell-typedependent manner. Proc Natl Acad Sci USA 95: 3931-3936.
Gelman IH, Silverstein S. 1986. Co-ordinate regulation o f herpes simplex virus gene
expression is mediated by the functional interaction o f two immediate early gene
products. J Mol Biol 191: 395^109.
Goodkin ML, Ting AT, Blaho JA. 2003. NF-{kappa}B is required for apoptosis
prevention during herpes simplex virus type 1 infection. J Virol 77: 7261-7280.
Greene LA, Tischler AS. 1976. Establishment o f a noradrenergic clonal line o f rat
adrenal pheochromocytoma cells which respond to nerve growth factor. Proc Natl Acad
Sci USA 73:2424-2428.
Greene LA. 1978. Nerve growth factor prevents the death and stimulated the neuronal
differentiation of rat adrenal pheochromocytoma cells in a serum-free medium. J Cell
Biol 78: 747-755.
Gregory D, Hargett D, Holmes D, Money E, Bachenheimer SL. 2004. Efficient
replication by herpes simplex virus type 1 involves activation o f the I {kappa} B kinaseI{kappa}B-[65 pathway. J Virol 78: 13582-13590.
Halford WP, Gephart BM, Carr DJ. 1996. Mechanisms o f herpes simplex virus type 1
reactivation. J Virol 70: 5051-5060.
Hamza MA, Higgins DM, Feldman LT, Ruyechan WT. 2007. The latency-associated
transcript of herpes simplex virus type 1 promotes survival and stimulates axonal
regeneration in sympathetic and trigeminal neurons. J NeuroVirol 13: 56-66.
Hay KA, Gaydos A, Tenser RB. 1995. The role of herpes simplex thymidine kinase
expression in neurovirulence and latency in newborn vs. adult mice. J Neuroimmunol 61 :
41-52.
49

Honess, R. W., and B. Roizman. 1974. Regulation of herpesvirus macromolecular
synthesis. I. Cascade regulation of the synthesis o f three groups of viral proteins. J. Virol.
14:8-19
Honess, R. W., D. J. M. Purifoy, D. Young, R. Gopal, N. Cammack, and P. O'Hare. 1984.
Single mutations at many sites within the DNA polymerase locus o f herpes simplex
viruses can confer hypersensitivity to aphidicolin and resistance to phosphonoacetic acid.
J. Gen. Virol. 65:1-17.
Jerome KR, Fox R, Chen Z, Sears AE, Lee H, Corey L. 1999. Herpes simplex virus
inhibits apoptosis through the action o f two genes, Us5 and Us3. J Virol. 73:8950-8957.
Jordan R, Pepe J, Schaffer PA. 1998. Characterization of a nerve growth factor-inducible
cellular activity that enhances herpes simplex virus type 1 gene expression and
replication of an ICPO null mutant in cells o f neural lineage. J Virol 72: 5373-5382.
Jordan R, Schaffer PA. 1997. Activation o f gene expression by herpes simplex virus type
1 ICPO occurs at the level of mRNA synthesis. J Virol 71: 6859-6862.
Kalamvoki M, Roizman B. 2009. ICPO enables and monitors the function o f D cyclins in
herpes simplex virus 1 infected cells. PNAS
www.pnas.org_cgi_doi_10.1073_pnas.0906905106 Accessed June 9, 2012.
Kawaguchi Y, Van Sant C, Roizman B. 19907. Herpes simplex virus 1 alpha regulatory
protein ICPO interacts with and stabilizes the cell cycle regulatory cyclin D3. J Virol 71:
7328-7336.
Kramer MF, Coen DM. 1995. Quantification o f transcripts from the ICP4 and thymidine
kinase genes in mouse ganglia latently infected with herpes simplex virus. J Virol 69:
1389-1399.
Laycock KA, Lee SF, Brady RH, Pepose IS. 1991. Characterization o f a murine model of
recurrent herpes simplex viral keratitis induced by ultraviolet B radiation. Invest
Opthalmol Vis Sci 32: 2741-2746.

50

Lee LY, Schaffer PA. 1998. A virus with a mutation in the ICP4-binding site in the L/ST
promoter of herpes simplex virus type 1, but not a virus with a mutation in open reading
frame P, exhibits cell-type-specific expression o f gamma(l)34.5 transcripts and latencyassociated transcripts. J Virol 72: 4250^1264.
Leib DA, Nadeau KC, Rundle SA, Schaeffer PA. 1991. The promoter o f the latencyassociated transcript of herpes simplex virus type 1 contains a functional cAMP-response
element: Role of the latency-associated transcripts and cAMP reactivation o f viral
latency. Proc Natl Acad Sci USS 88: 48-52.
Leopardi R, Roizman B. 1996. The herpes simplex virus major regulatory protein ICP4
blocks apoptosis induced by the virus or by hypothermia. Proc Natl Acad Sci USA. 93:
9583-9587.
Leopardi R, Van Sant C, Roizman B. 1997. The herpes simplex virus 1 protein kinase
US3 is required for protection from apoptosis induced by the virus. Proc Natl Acad Sci
USA 94: 7891-7896.
Liu M, Rakowski B, Gershburg E, Weisend CM, Lucas O, Schmidt EE, Halford WP.
2010. ICPO antagonizes ICP4-dependent silencing o f the herpes simplex virus ICPO gene.
PLoS ONE 5: e8837. doi:10.1371/joumal.pone.0008837
Mavromara-Nazos, P., S. Silver, J. Hubenthal-Voss, J. L. McKnight, and B. Roizman.
1986. Regulation of herpes simplex virus 1 genes: alpha gene sequence requirements for
transient induction of indicator genes regulated by beta or late (gamma 2) promoters.
Virology 149:152 164.
Meijer L, Borgne A, Mulner O, Chong JPJ, Blow HH, Inagaki N, Inagaki M, Delcros J,
Moulinoux J. 1997. Biochemical and ceullar effects of Roscovitine, a potent and selective
inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5. Eur J Biochem 243: 527536.
Michael N, Roizman B. 1993. Repression of the herpes simplex virus 1 alpha 4 gene by
its gene product occurs within the context o f the viral genome and is associated with all
three identified cognate sites. Proc Natl Acad Sci U S A 90:2286-2290.
51

Miller CS, Danaher RJ, Jacob RJ. 2006. ICPO is not required for efficient stress-induced
reactivation of herpes simplex virus type 1 from cultures quiescently infected neuronal
cells. J Virol 80: 3360-3368.
Miller CS, Bhattacharjee PS, Higaki S, Jacob RJ, Danaher RJ, Thompson HW, Hill JM.
2003. Herpesvirus quiescence (QIF) in neuronal cells VI: Correlative analysis
demonstrates usefulness of QIF-PC12 cells to examine HSV-1 latency, reactivation, and
genes implicated in its regulation. Curr Eye Res 26: 239-248.
Mitchell WJ. 1995. Neurons differentially control expression of a herpes simplex virus
type 1 immediate-early promoter in transgenic mice. J Virol 69: 7942-7950.
Mossman KI, Smiley JR. 1999. Truncation o f the C-terminal acidic transcriptional
activation domain of herpes simplex virus VP 16 renders expression o f the immediateearly genes almost entirely dependent on ICPO. J Virol 73: 9726-9733.
Moxley MJ, Block TM, Liu H, Fraser NW, Perng G, Wechsler SL, Su Y. 2002. Herpes
simplex virus type 1 infection prevents detachment o f nerve growth factor-differentiated
PC 12 cells in culture. J Gen Virol 83: 1591-1600.
Munger J, Chee A, Roizman B. 2001. The Us3 protein kinase blocks apoptosis induced
by the dl20 mutant of herpes simplex virus 1 at premitochondrial stage. J Virol 75: 54915497.
Nagai M, Sakakibara J, Wakui K, Fukishima Y, Igarashi S, Tsuji S, Arakawa M, Ono T.
1997. Localization of the squalene epoxidase gene (SQLE) to human chromosome region
8q24.1. Genomic 44: 141-143.
Patel A, Hanson J, McLean TI, Olgiate J, Hilton M, Miller WE, Bachenheimer SL. 1998.
Herpes simplex virus type 1 inductions o f persistent NF-[kappa]B nuclear translocation
increases the efficiency of virus replication. Virology 247: 212-222.
Pereira, L., M. H. Wolff, M. Fenwick, and B. Roizman. 1977. Regulation of herpesvirus
macromolecular synthesis. V. Properties of alpha polypeptides made in HSV-1 and HSV2 infected cells. Virology 77:733-749.
52

Polyak K, Lee MH, Erdjument-Bromage H, K off A, Roberts JM, Tempst P, Massague J.
1994. Cloning of p27K ipl, a cyclin-dependent kinase inhibitor and a potential mediator
of extracellular antimitogenic signals. Cell 78: 59-66.
Post, L. E., S. Mackem, and B. Roizman. 1981. Regulation of alpha genes o f herpes
simplex virus: expression of chimeric genes produced by fusion of thymidine kinase with
alpha gene promoters. Cell 24:555-565.
Purifoy, D. J., and K. L. Powell. 1976. DNA-binding proteins induced by herpes simplex
virus type 2 in HEp-2 cells. J. Virol. 19:717-731.
Rider CH, Zook CE, Boetcher TL, Wick ST, Pancoast JS, Zusman BJ. 2011. Broadspectrum antiviral therapeutics. PLoS ONE 6: e22572. doi: 10.1371/joumal.pone.0022572
Rock D, Fraser NW. 1983. Detection of HSV-1 DNA in central nervous systems of
latently infected mice. Nature 302: 523-525.
Sawtell NM, Thompson RL. 1992. Rapid in vivo reactivation o f herpes simplex virus in
latently infected murine ganglionic neurons after transient hyperthermia. J Virol 66:
2150-2156.
Schang LM, Rosenberg A, Schaffer PA. 1999. Transcription o f herpes simplex virus
immediate-early and early genes is inhibited by Roscovitine and inhibitor specific for
cellular cyclin-dependent kinases. J. Virol. 73: 2161-2172.
Schaffer PA, Aron GM, Bemyesh-Meinick M. 1973. Temperature sensitive mutants of
HSV 1 isolation, complementation, and partial chatacterization. J Virol 52: 57-71.
Sharma P, Veeranna, Sharma M, Amin N D, Sihag RK, Grant P, Ahn N, Kulkami AB,
Pant HC. 2002. Phosphorylation of MEK1 by cdk5/p35 down-regulates the mitogenactivated protein kinase pathway. J Biol Chem. 277, 528-534.
Smith RL, Pizer LI, Johnson EM, Eilcox CL. 1992. Activation o f second-messenger
pathways reactivates latent herpes simplex virus in neuronal cultures. Virology 188: 311318.

53

Stevens, J.G. 1975. Latent herpes simplex vims and the nervous system. Current Topics
in Microbiology and Immunology. 70:31-50.
Stevens JG, Wagner EK, Devi-Rao G, Cook ML, Feldman L. 1987. RNA complimentary
to a herpesvirus alpha gene mRNA is predominant in latently infected neurons. Science
235:1056-1059.
Su Y, Meegalla RL, Chowhan R, Cubitt C, Oakes JE, Lausch RN, Fraser NW, Block
TM. 1999. Human comeal cells and other fibroblasts can stimulate the appearance of
herpes simplex virus form quiescently infected PC 12 cells. J Virol 73: 4171-4180.
Su Y, Moxley M, Kejariwai R, Mehta A, Fraser NW, Block TM. 2000. The HSV 1
genome in quiescently infected NGF differentiated PC 12 cells cannot be stimulated by
HSV superinfection. JNeuroVirol 6: 341-349.
Su Y, Moxley M, Ng AK, Lin J, Jordan R, Fraser NW, Block TM. 2002. Stability and
circularization of herpes simplex vims type 1 genomes in quiescently infected PC 12
cultures. J Gen Virol 83: 2943-2950.
Taddeo B, Luo TR, Zhang W, Roizman B. 2003. Activation o f NF-{kappa}B in cells
productively infected with HSV-1 depends on activated protein kinase R and plays no
apparent role in blocking apoptosis. Proc Natl Acad Sci USA 100: 12408-12413.
Taddeo B, Zhang W< Lakeman F, Roizman B. 2004. Cells lacking NF-{kappa}B or in
which NF={kappa} B is not activated vary with respect in ability to sustain herpes
simplex virus 1 replication and are not susceptible to apoptosis induced by a replicationincompetent mutant vims. J Virol 78: 11615-11621.
Tal-Singer, R., Lasner, T. M., Podrzuckl, W., Skokotas, A., Leary, J. J.,Berger, S. L. &
Fraser, N. W. (1997). Gene expression during reactivation o f herpes simplex vims type 1
from latency in the peripheral nervous system is different from that during lytic infection
of tissue cultures. Journal of Virology 71, 5268-5276.
Thomas SK, Gough G, Latchman DS, Coffin RS. 1999. Herpes simplex virus latencyassociated transcript encodes a protein which greatly enhances virus growth, can

54

compensate for deficiencies in immediate-early gene expression, and is likely to function
during reactivation from virus latency. J Virol 73: 6618-6625.
Valyi-Nagy T, Deshmane S, Dillner A, Fraser NW. 1991. Inductions o f cellular
transcription factors in trigeminal ganglia of mice by corneal scarification, herpes
simplex virus type 1 infection, and explantation o f trigeminal ganglia. J Virol 65: 41424152.
Wander AH, Centifanto YM, Kaufman HE. 1980. Strain specificity o f clinical isolates of
herpes simplex virus. Arch Opthalmol 98: 1458-1467.
Ward, P.I., and Roizman, B. 1994. Herpes simplex genes: the blueprint o f a successful
human pathogen. Trends Genet. 10:267-274.
Wilcox CL, Johnson EM. 1988. Characterization of nerve growth factor-dependent
herpes simplex virus latency in neurons in vitro. J Virol 61: 2311-2315.
Willard M. 2002. Rapid directional translocations in virus replication. J Virol 10: 52205232
Yedowitz JC, Blaho JA. 2005. Herpes simplex virus 2 modulates apoptosis and
stimulates NF-{kappa} B nuclear translocation during infection in human epithelial HEp2 cells. Virology 74: 11782-11791.
Zheng Y, Li B, Kanugo J, Kesavapany S, Amin N, Grant P, Pant HC. 2007. Cdk5
modulation of mitogen-activated protein kinase signaling regulate neuronal survival. Mol
Biol Cell 18:404-413.
Zhou G, Roizman B. 2000. Wild-type herpes simplex virus 1 blocks programmed cell
death and release of cytochrome c but not the translocation o f mitochondrial apoptosisinducing factor to the nucleus of human embryonic lung fibroblasts. J Virol 74: 90489053.

55

